Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients

Marcela Valverde‐Monge, Patricia Sánchez-Carrasco, Diana Betancor, Blanca Barroso, José M. Rodrigo‐Muñoz, Ignacio Mahíllo, Ebymar Arismendi, Irina Bobolea, Blanca Cárdaba, María Jesús Cruz, Victoria del Pozo, Javier Domínguez‐Ortega, Francisco Javier González‐Barcala, José M. Rivera, Juan Alberto Luna-Porta, Carlos Martínez‐Rivera, Joaquim Mullol, Xavier Muñoz, Lorena Peleteiro-Pedraza, César Picado Vallés, Vicente Plaza, Santiago Quirce, Manuel J. Rial, Lorena Soto‐Retes, Antonio Valero, J. Sastre